Successful Photodynamic Therapy for Nonresectable Cholangiocarcinoma: A Randomized Prospective Study

Gastroenterology

Volumn 125, Issue 5, 2003, Pages 1355-1363

  Ortner, Marianne E J ^a   Caca, Karel ^b   Berr, Frieder ^c   Liebetruth, Jochen ^d   Mansmann, Ulrich ^e   Huster, Dominik ^b   Voderholzer, Winfried ^d   Schachschal, Guido ^d   Mössner, Joachim ^b   Lochs, Herbert ^d  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c St Johanns Spital   (Austria)

^d HUMBOLDT UNIVERSITY   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; PHOTOFRIN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILE DUCT TUMOR; BILIARY TRACT DRAINAGE; CACHEXIA; CHOLANGITIS; CHOLESTASIS; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOPROSTHESIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HEART FAILURE; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; LUNG EMBOLISM; LUNG METASTASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOMES RESEARCH; PALLIATIVE THERAPY; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PERITONEUM METASTASIS; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEPSIS; STENT; SURVIVAL; SURVIVAL TIME;

EID: 0242658698     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gastro.2003.07.015     Document Type: Article

References (60)

1. Smith AC, Dowse JF, Russell RC, Hatfield AR, Cotton PB. Randomized trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994;344:1655-1660.
2. Ahrendt SA, Nakeeb A, Pitt HA. Cholangiocarcinoma. Clin Liver Dis 2001;5:191-218.
3. Havlik R, Sbisa E, Tullo A, Kelly MD, Mitry RR, Jiao LR, Mansour MR. Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors. Hepatogastroenterology 2000;47:927-931.
4. Reed DN Jr, Vitale GC, Martin R, Bas H, Wieman TJ, Larson GM, Edwards M, McMasters K. Bile duct carcinoma: trends in treatment in the nineties. Am Surg 2000;66:714-715.
5. Pichlmayr R, Weimann A, Klempnauer J, Oldhafer KJ, Maschek H, Tusch G, Ringe B. Surgical treatment in proximal bile duct cancer: single-center experience. Ann Surg 1996;217:20-27.
6. Blom D, Schwartz SI. Surgical treatment and outcomes in carcinoma of the extrahepatic bile ducts: the University of Rochester experience. Arch Surg 2001;136:209-215.
7. Byrke V, Afdhal N. Cholangiocarcinoma of the hepatic hilum (Klatskin tumor). Curr Treat Options Gastroenterol 2002;5:87-94.
8. Johnson SR, Kelly BS, Pennington U, Hanto DW. A single center experience with extrahepatic cholangiocarcinomas. Surgery 2001;130:584-590.
9. Bhuya MMR. Clinicopathologic factors influencing survival of patients with bile duct carcinoma. World J Surg 1993;17:653-657.
10. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomized trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992;34:1488-1492.
11. Schmassmann A, von-Gunten E, Knuchel J, Scheurer U, Fehr HF, Halter F. Wall stents versus plastic stents in malignant biliary obstruction: effect of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol 1996; 91:654-659.
12. Born P, Rosch T, Bruhl K, Sandschin W, Weigert N, Ott R, Frimberg E, Allescher HD, Hoffmann W, Neuhaus H, Classen M. Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainage. Z Gastroenterol 2000;38:483-489.
13. Peters RA, Williams SG, Lombard M, Karani J, Westaby D. The management of high-grade hilar strictures by endoscopic insertion of self-expending metal endoprostheses. Endoscopy 1997; 29:10-16,
14. Prat F, Chapat O, Ducot B, Ponchon T, Pelletier G, Fritsch J, Choury AD, Buffet C. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc 1998;47:1-7.
15. Prat F, Chapat O, Ducot B, Ponchon T, Fritsch J, Choury AD, Pelletier G, Buffet C. Predictive factors of survival of patients with inoperable malignant distal biliary strictures: a practical management guideline. Gut 1998;42:76-80.
16. Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998;228:385-394.
17. Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998;47:354-362.
18. Polydorou AA, Cairns SR, Dowsett JF, Hatfield AR, Salmon PR, Cotton PB. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut 1991;32:685-689.
19. Ducreux M, Liguory C, Lefevre JF, Ink O, Choury A, Fritsch J, Bonnel D, Derhy S, Etienne JP. Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors. Dig Dis Sci 1992;37:778-783.
20. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975;140:170-178.
21. Van Groeningen CJ. Intravenous and intra-arterial chemotherapeutic possibilities in biliopancreatic cancer. Ann Oncol 1999; 10:305-307.
22. Bowling TE, Galbraith SM, Hatfield AR, Solano J, Spittle MF. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut 1996;39:852-855.
23. Shinchi H, Takao S, Nishida H, Aikou T. Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma. J Surg Oncol 2000;75:89-94.
24. Miura Y, Endo I, Togo S, Sekido H, Misuta K, Fujii Y, Kubota T, Tanaka K, Nagahori K, Shimada H. Adjuvant therapies using biliary stenting for malignant biliary obstruction. J Hepatobiliary Pancreat Surg 2001;8:113-117.
25. Tsujino K, Landry JC, Smith RG, Keller JW, Williams WH, Davis LW. Definitive radiation therapy for extrahepatic bile duct carcinoma. Radiology 1995;196:275-280.
26. McCaughan JS Jr, Mertens BF, Cho C, Barabash RD, Payton HW. Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. Arch Surg 1991;126:111-113.
27. Ortner MA, Liebetruth J, Schreiber S, Hanft M, Wruck U, Fusco V, Muller JM, Hortnagl H, Lochs H. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998;114:536-542.
28. Berr F, Wiedmann M, Tannapfel A, Halm U, Kohlhaw KR, Schmidt F, Wittekind C, Hauss J, Mossner J. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 2000;31:291-298.
29. Ortner MA. Photodynamic therapy of cholangiocarcinoma cancer. Gastrointest Endosc Clin North Am 2000;10:481-486.
30. Rumalla A, Baron TH, Wang KK, Gores GJ, Stadheim LM, de Groen PC. Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc 2001;53:500-504.
31. Zoepf T, Jakobs R, Arnold JC, Apel D, Rosenbaum A, Riemann JF. Photodynamic therapy for palliation of non-resectable bile duct cancer-preliminary results with a new diode laser system. Am J Gastroenterol 2001;96:2093-2097.
32. Foote CS. Definition of type I and type II photosensitized oxidation. Photochem Photobiol 1991;54:659.
33. Fingar VH, Wieman TJ. Studies on the mechanism of photodynamic therapy induced tumor destruction. Proc Soc Photo/Opt Instrum Eng 1990;1203:168-177.
34. 2 from cells by photodynamic treatment in vitro. Cancer Res 1989;49:6869-6890.
35. Hsi RA, Rosenthal DI, Glatstein E. Photodynamic therapy in the treatment of cancer. Drugs 1999;57:725-734.
36. Wong Kee Song LM, Wang KK, Zinsmeister AR. Mono-I-aspartat chlorin e6 (NPe6) and hematoporphyrin derivate (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model. Cancer 1998;82:421-427.
37. Zoepf T, Jakobs R, Rosenbaum A, Apel D, Arnold JC, Riemann JF. Photodynamic therapy with 5-aminolaevulinic acid is not effective in bile duct cancer. Gastrointest Endosc 2001;54:763-766.
38. TNM staging criteria. Group staging criteria UICC/AJCC. 5th ed. 3rd revision. Berlin: Springer Verlag, 1997.
39. Greene FL, Sobin LH. The TNM system: our language for cancer care. J Surg Oncol 2002;80:119-120.
40. Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinoma. Semin Liver Dis 1994;14:109-114.
41. Karnofsky DA, Abelman WH, Craver LF, Burchard JH. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634-656.
42. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, and the EORTC Study Group on Quality of Life. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
43. Fayers PM, Hand DJ. Generalization from phase III clinical trials: survival, quality of life and health economics. Lancet 1997;350:1025-1027.
44. Whitehead J. Planning and evaluation of sequential trials. The design and analysis of sequential clinical trials. 2nd ed revised. Chichester: Wiley, 1997.
45. Jennison C, Turnbull BW. Group sequential methods with applications to clinical trials. Boca Raton: Chapman & Hall, 2000.
46. Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. New York: Springer-Verlag, 1997.
47. Hochwald SN, Burke EC, Jarnagin WR, Fong Y, Blumgart LH. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 1999;134:261-266.
48. Liu CL, Lo CM, Lai EC, Fan ST. Endoscopic retrograde cholangiopancreaticography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg 1998;133:293-296.
49. Deviere J, Baize M, deToeuf J, Cremer M. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal drainage. Gastrointest Endosc 1988;34:95-101.
50. Gerhards MF, den Hartog D, Rauws EA, Van Gulik TM, Gonzalez D, Lameris JS, de Witt LT, Gouma DJ. Palliative treatment in patients with unresectable hilar cholangiocarcinoma: results of endoscopic drainage in patients with type III and IV hilar cholangiocarcinoma. Eur J Surg 2001;167:274-280.
51. England RE, Martin DF, Morris J, Sheridan MB, Frost R, Freeman A, Lawrie B, Deakin M, Fraser I, Smith K. A prospective randomized multicenter trial comparing 10 Fr Teflon Tannenbaum stents with 10 Fr polyethylene Cotton-leung stents in patients with malignant common duct strictures. Gut 2000;46:395-400.
52. Glimelius B, Hoffman K, Sjoden PO, Jacobsson G, Sellstrom H, Enander LK, Linne T, Svensson C. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996;7:593-600.
53. Lammer J, Hausegger KA, Fluckiger F, Winkelbauer FW, Wildling R, Klein GE, Thurnher SA, Havelek L. Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology 1996;201:167-172.
54. Ferlitsch A, Oesterreicher C, Dumonceau JM, Deviere J, Leban T, Born P, Rosch T, Suter W, Binek J, Meyenberger C, Mullner M, Schneider B, Schofl R. Diamond stents for palliation of malignant bile duct obstruction: a prospective multicenter evaluation. Endoscopy 2001;33:645-650.
55. Schoder M, Rossi P, Uflacker R, Bezzi M, Stadler A, Funovics MA, Cejna M, Lammer J. Malignant biliary obstruction: treatment with ePTFE-FEP-covered endoprostheses initial technical and clinical experiences in a multicenter trial. Radiology 2002;225:35-42.
56. Terruzzi V, Comin U, De Grazia F, Toti GL, Zambelli A, Beretta S, Minoli G. Prospective randomized trial comparing Tannenbaum Teflon and standard polyethylene stents in distal malignant biliary stenosis. Gastrointest Endosc 2000;51:23-27.
57. Brountzos EN, Petropoulos E, Kelekis NL, Magoulas D, Alexopoulos E, Kagianni E, Kelekis DA. Malignant biliary obstruction: management with percutaneous metallic stent placement. Hepatogastroenterology 1999;46:2764-2771.
58. Cheng JL, Bruno MJ, Bergman JJ, Rauws EA, Tytgat GN, Huibregtse K. Endoscopic palliation of patients with biliary obstruction accused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest Endosc 2002;56:33-39.
59. Wagner HJ, Knyrim K, Vakil N, Klose KJ. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy 1993;25:213-218.
60. Dumoulin FL, Gerhardt T, Fuchs S, Scheurlen C, Neubrand M, Layer G, Sauerbruch T. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc 2003;57:860-867.